Improving energy efficiency in process systems is a major challenge in the transition toward more sustainable chemical, electrochemical, and environmental ...

Process intensification has become a hot topic in biopharma in recent years, with concepts like continuous manufacturing and “scaling-out” increasingly cited as investment drivers by drug firms and ...

Increasing peptide complexity, broader portfolio diversity and rapidly changing volume requirements are placing growing constraints on conventional peptide manufacturing models. At the same time, ...

As demand for biologics surges, the biopharmaceutical industry is under pressure to increase productivity and flexibility as well as shorten production timelines. At the same time, there is the need ...